Patent Assignment
Reel/Frame 050478/0204
SECURITY INTEREST
Recorded: 2019-09-24
Received: 2019-09-24
Pages: 7
Assignor
AEGERION PHARMACEUTICALS, INC.
Executed: 2019-09-24
Assignee
CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
110 EAST 59TH STREET, NEW YORK, NY, 10022, UNITED STATES
Covered Applications
(6)
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
App. No. 15/882,919
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 15/570,246
→
Methods of Detecting Anti-Leptin Neutralizing Antibodies
App. No. 15/702,719
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 14/800,537
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→